Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
Drugs

Lincomycin-Darnitsa

Systemic antibacterial agents. Lincosamides

Lincomycin is a lincosamide antibiotic, a product of Streptomyces lincolniensis. Inhibits bacterial protein synthesis due to reversible binding to 50S ribosomal subunit, interferes with peptide bond formation.

Treatment of severe infections caused by lincomycin-susceptible strains of Streptococci, Pneumococci, and Staphylococci. The use of this drug should be restricted to patients allergic to penicillin, or to other patients treating whom with penicillin is inappropriate in the physician's opinion.

A skin sensitivity test is required before using the drug.

Adults.

A. Intramuscular injection.

The usual dose is:

1. 600 mg intramuscularly every 24 hours.

2. More severe infections: 600 mg intramuscularly every 12 hours (or more frequently), determined by the severity of the infection.

B. Intravenous injection.

The usual dose is:

600 mg to 1 g every 8–12 hours.
In more severe infections, the doses may be increased.
In life-threatening conditions, the daily dose for intravenous administration may be up to 8 g.

Specialized edition for medical institutions and doctors.